MANNKIND CORP (MNKD) 2.98 -0.02 (-0.67%)
2.98 -0.02 (-0.67%)
US56400P7069 - Common Stock
MannKind Corporation to Participate in the Lytham Partners Fall 2022 Investor Conference
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Sept. 21, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development...
7 Penny Stocks That Actually Have a Buy Rating
Penny stocks are always a risky proposition. However, investors can still find penny stocks with buy ratings right now.
Interesting MNKD Call Options For October 28th
Mannkind Successfully Completes Phase 1 Study of Inhaled Clofazimine
Study supports the dosing regimen that will be pursued in further clinical programsNo serious adverse events or QT prolongation identifiedPlanning underway...
MannKind Corporation to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development...
September 30th Options Now Available For MannKind (MNKD)
MannKind Corporation Reports 2022 Second Quarter Financial Results
Conference Call to Begin Today at 5:00 p.m. (ET) Tyvaso DPI™ approved by the FDA in May representing the second FDA-approved product using the...
September 23rd Options Now Available For MannKind (MNKD)
MannKind Corporation to Hold 2022 Second Quarter Financial Results Conference Call on August 9, 2022
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will release its 2022 second quarter...
MannKind Corporation to Participate in the BTIG Biotechnology Conference
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development...
Interesting MNKD Put And Call Options For August 26th
Mannkind to Host Product Theater and Booth at the American Diabetes Association’s 82nd Scientific Sessions in New Orleans, June 3-7
WESTLAKE VILLAGE, Calif., June 03, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and...
July 22nd Options Now Available For MannKind (MNKD)
MannKind (MNKD) Shares Cross Below 200 DMA
July 8th Options Now Available For MannKind (MNKD)
MannKind’s Technosphere® Inhalation Platform Utilized in FDA-Approved Tyvaso DPI™
Tyvaso DPI represents the second FDA-approved product utilizing MannKind’s Technosphere® inhalation technologyFirst approval of a dry powder inhaled...
Noteworthy Monday Option Activity: TBPH, MNKD, CRMT
First Week of July 15th Options Trading For MannKind (MNKD)
MannKind Corporation to Ring the Nasdaq Stock Market Opening Bell
WESTLAKE VILLAGE, Calif. and DANBURY, Conn., May 19, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development...
MannKind Corporation Announces Agreement to Acquire V-Go® Insulin Delivery Device From Zealand Pharma
The once-daily insulin delivery device strengthens MannKind’s commitment to offering innovative mealtime diabetes solutions DANBURY, Conn. and WESTLAKE...
7 Biotech Stocks With Key Catalysts for May
The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns.
MannKind Corporation Participating at Upcoming Conferences
WESTLAKE VILLAGE, Calif. and DANBURY, Conn., May 09, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development...
MannKind Corporation Reports 2022 First Quarter Financial Results
Conference Call to Begin Today at 5:00 p.m. (ET)...
June 24th Options Now Available For MannKind (MNKD)